Humeral Compression/Distraction Device

NCT ID: NCT02861495

Last Updated: 2018-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2018-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed study of humeral shaft fractures in adults will examine outcomes in patients treated with the Humeral Trauma Nail System to treat displaced humeral shaft fractures (displaced OTA code 12A, B, or C), nonunions, or malunions. The device to be studied uses an internal gear system controlled wirelessly by rare earth magnets, which typically offers distraction for lengthening. In the humerus however, during the treatment of acute fractures, this percutaneously inserted nail can also offer compression during the healing process, thereby negating the effect of gravity, which may in turn lead to a faster and more consistent rate of union. Furthermore, in cases of slower healing the dynamic properties of the nail may employ an "accordion technique" (alternating compression-distraction, a feature unique to this implant.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary end point will be the union rate without secondary procedures. The hypothesis is that with the compression and distraction that this device makes possible, the investigators can achieve a higher union rate than with other forms of treatment, using a percutaneous approach, with a decreased complication rate, and can dynamically modulate the healing response when needed. The primary safety endpoint is the occurrence of adverse events from the time of treatment.

During the healing process an external remote controller (ERC) will be used to continually compress or distract the fracture as needed. The surgeon will monitor healing and decide, clinically based on sequential radiographs during subsequent office visits, whether the fracture needs additional compression or distraction, an accordion technique, or no additional external manipulation via the ERC. Participants will be followed for 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Humeral Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

humeral nail

Surgical fixation with a humeral compression/distraction nail.

Group Type EXPERIMENTAL

Humeral Compression/Distraction (CD) Nail

Intervention Type DEVICE

Surgical fixation of humeral shaft fractures with Humeral Compression/Distraction (CD) Nail implant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Humeral Compression/Distraction (CD) Nail

Surgical fixation of humeral shaft fractures with Humeral Compression/Distraction (CD) Nail implant

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult skeletally mature patients 18 years or older, treated by the Orthopaedic Trauma Service at Tampa General Hospital, and the Trauma Service at St. Louis University Hospital

* Open or closed displaced humeral shaft fractures (displaced OTA code 12A, B, or C), nonunions or malunions
* amenable to treatment with an intramedullary nail

Exclusion Criteria

* Intra-articular extension of the fracture, prohibiting treatment with an intramedullary nail;
* Pathologic fracture
* Retained hardware
* Patients with pacemakers
* Age under 18 years.
* Patients who are prisoners or likely to become prisoners
* Homeless, or those likely to have difficulty making follow-up appointments
* Pregnancy
* Ipsilateral nerve or vascular injuries
* Immunocompromised patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NuVasive

INDUSTRY

Sponsor Role collaborator

St. Louis University

OTHER

Sponsor Role collaborator

Florida Orthopaedic Institute

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roy W Sanders, MD

Role: PRINCIPAL_INVESTIGATOR

Florida Orthopaedic Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tampa General Hospital

Tampa, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PTH Analog Type II Odontoid Fracture
NCT04760782 TERMINATED PHASE2
Perform® Humeral System - Fracture Study (PFX)
NCT05773352 ACTIVE_NOT_RECRUITING
New Tools for Assessing Fracture Risk
NCT02436356 TERMINATED NA